{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T16:29:18Z","timestamp":1747067358895},"reference-count":14,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Optometry - Journal of the American Optometric Association"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.optm.2010.09.001","type":"journal-article","created":{"date-parts":[[2010,11,25]],"date-time":"2010-11-25T09:35:49Z","timestamp":1290677749000},"page":"658-662","source":"Crossref","is-referenced-by-count":7,"title":["Intraocular pressure elevation from topical difluprednate use"],"prefix":"10.1016","volume":"81","author":[{"given":"Kelly","family":"Meehan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Vollmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Sowka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.optm.2010.09.001_bib1","first-page":"125","article-title":"The position not the presence of the halogen in corticosteroids influences potency and side effects","volume":"5","author":"Bikowski","year":"2006","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.optm.2010.09.001_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcrs.2008.09.024","article-title":"Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain","volume":"35","author":"Korenfeld","year":"2009","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.optm.2010.09.001_bib3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00055735-200012000-00016","article-title":"Management Ocular complications of topical, peri-ocular, and systemic corticosteroids","volume":"11","author":"Carnahan","year":"2000","journal-title":"Curr Opin Opthalmol"},{"issue":"6","key":"10.1016\/j.optm.2010.09.001_bib4","first-page":"815","article-title":"New drugs: Clevidipine butyrate, difluprednate, and tetrabenazine. J Am Pharm Assoc","volume":"48","author":"Hussar","year":"2008","journal-title":"2003"},{"issue":"2","key":"10.1016\/j.optm.2010.09.001_bib5","first-page":"163","article-title":"Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature","volume":"17","author":"Jones","year":"2006","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.optm.2010.09.001_bib6","series-title":"Duane's biomedical foundations of ophthalmology. Vol. 1","first-page":"1","article-title":"Functional anatomy of the anterior chamber angle","author":"Tripathi","year":"1989"},{"key":"10.1016\/j.optm.2010.09.001_bib7","first-page":"381","article-title":"The role of difluprednate ophthalmic emulsion in clinical practice","volume":"3","author":"Jamal","year":"2009","journal-title":"Clin Ophthalmol"},{"issue":"1-2","key":"10.1016\/j.optm.2010.09.001_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijpharm.2005.05.036","article-title":"Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate","volume":"301","author":"Yamaguchi","year":"2005","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.optm.2010.09.001_bib9","first-page":"102","article-title":"The downside of tear preservatives","volume":"9","author":"Abelson","year":"2002","journal-title":"Rev Opthalmol"},{"issue":"6","key":"10.1016\/j.optm.2010.09.001_bib10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1055\/s-2004-814578","article-title":"Pharmacodynamics and pharmacokinetics of synthetic mineralocorticoids and glucocorticoids: receptor transactivation and prereceptor metabolism by 11beta-hydroxysteroid-dehydrogenases","volume":"36","author":"Diederich","year":"2004","journal-title":"Horm Metab Res"},{"issue":"2","key":"10.1016\/j.optm.2010.09.001_bib11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/bjo.69.2.120","article-title":"Efficacy in anterior uveitis of two known steroids and topical tolmetin","volume":"69","author":"Dunne","year":"1985","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.optm.2010.09.001_bib12","unstructured":"Ohno S, Mochizuki M, Usui M, et\u00a0al. A phase III noninferiority study of difluprednate ophthalmic emulsion 0.05% in the treatment of anterior uveitis. Poster presented at: The 2007 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO); May 6-10, 2007; Ft. Lauderdale, FL. Poster B808, Program 3904."},{"key":"10.1016\/j.optm.2010.09.001_bib13","unstructured":"Mochizuki M, Ohno S, Usui M, et\u00a0al. A phase III open-label clinical study of difluprednate ophthalmic emulsion 0.05% in the treatment of severe refractory anterior uveitis. Poster presented at: The 2007 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO); May 6-10, 2007; Ft. Lauderdale, FL, USA. Poster B809, Program 3905."},{"key":"10.1016\/j.optm.2010.09.001_bib14","unstructured":"Sirion Therapeutics, Inc. Tampa, FL. A phase III multicenter, randomized, double-masked study of the safety and efficacy of difluprednate 0.05% ophthalmic emulsion compared to prednisolone acetate 1% ophthalmic suspension in the treatment of endogenous anterior uveitis Dec; 2008. Data on file."}],"container-title":["Optometry - Journal of the American Optometric Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529183910004604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529183910004604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T16:22:27Z","timestamp":1544113347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1529183910004604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1529183910004604"],"URL":"https:\/\/doi.org\/10.1016\/j.optm.2010.09.001","relation":{},"ISSN":["1529-1839"],"issn-type":[{"value":"1529-1839","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}